EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma

Jungnam Lee, Young-Joo Jin iD, Seung Kak Shin, Jung Hyun Kwon iD, Sang Gyune Kim iD, Jung Hwan Yu, Jin-Woo Lee, Oh Sang Kwon, Soon Woo Nahm, Young Seok Kim iD

Journal of Gastroenterology and Hepatology · 2024

DOI: 10.1111/jgh.16581 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Jungnam Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, South Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Inha University Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Transarterial chemoembolization (TACE) is one of the standard modalities used to treat unresectable hepatocellular carcinoma (HCC), but the effectiveness of TACE for treating patients with a solitary small (≤3 cm) HCC and well‐preserved liver function has not been definitively established. This study aimed to determine the therapeutic impact of TACE in patients with these characteristics.

Methods

This multicenter (four university hospitals) retrospective cohort study analyzed the medical records of 250 patients with a solitary small (≤3 cm) HCC and Child–Turcotte–Pugh (CTP) class A liver function diagnosed over 10 years. Posttreatment outcomes, including overall survival (OS), recurrence‐free survival (RFS), and adverse events, were assessed following TACE therapy.

Results

One hundred and thirty‐eight of the 250 patients (55.2%) treated with TACE achieved complete remission (CR). Overall median OS was 77.7 months, and median OS was significantly longer in the CR group than in the non‐CR group (89.1 vs. 58.8 months, P = 0.001). Median RFS was 19.1 months in the CR group. Subgroup analysis identified hypertension, an elevated serum albumin level, and achieving CR as significant positive predictors of OS, whereas diabetes, hepatitis c virus infection, and tumor size (>2 cm) were poor prognostic factors of OS.

Conclusions

The study demonstrates the effectiveness of TACE as a viable alternative for treating solitary small (≤3 cm) HCC in CTP class A patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsChemoembolization, TherapeuticHumansMaleFemaleRetrospective StudiesMiddle AgedAgedTreatment OutcomeCohort StudiesSurvival RateAdultAged, 80 and overRemission Induction

Stichwörter der Autor:innen

Child–Turcotte–Pughhepatocellular carcinomaoverall survivaltransarterial chemoembolization

Autor:innen und Institutionen

  • Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, South Korea.
  • Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea.
  • Department of Internal Medicine, The Catholic University of Korea Incheon St. Mary's Hospital, Incheon, South Korea.
  • Department of Internal Medicine, Soonchunhyang University Hospital Bucheon, Bucheon, South Korea.

ORCID-Profile: Young-Joo Jin, Jung Hyun Kwon, Sang Gyune Kim, Young Seok Kim

Förderung

  • Inha University Research

Zitieren

APA

Lee, J., Jin, Y. J., Shin, S. K., Kwon, J. H., Kim, S. G., Yu, J. H., Lee, J. W., Kwon, O. S., Nahm, S. W., & Kim, Y. S. (2024). Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16581

Vancouver

Lee J, Jin YJ, Shin SK, Kwon JH, Kim SG, Yu JH, et al. Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16581

BibTeX
@article{Lee2024,
  author = {Lee, Jungnam and Jin, Young-Joo and Shin, Seung Kak and Kwon, Jung Hyun and Kim, Sang Gyune and Yu, Jung Hwan and Lee, Jin-Woo and Kwon, Oh Sang and Nahm, Soon Woo and Kim, Young Seok},
  title = {Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1111/jgh.16581}
}
Kostenlos starten →